Clarity in cell line development

Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

  21st February 2019: Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s …

Read more Valitacell and Solentim announce collaboration to accelerate discovery and development of biologic drugs and advanced cell therapies

Collaboration: changing CLD practices

In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell line development. But what exactly are the tangible benefits gained from both parties and for customers, and why does this fusion of technology offer more …

Read more Collaboration: changing CLD practices